Esra Karslioglu French

970 total citations
29 papers, 644 citations indexed

About

Esra Karslioglu French is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Esra Karslioglu French has authored 29 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Genetics and 8 papers in Surgery. Recurrent topics in Esra Karslioglu French's work include Thyroid Cancer Diagnosis and Treatment (13 papers), Diabetes Management and Research (11 papers) and BRCA gene mutations in cancer (8 papers). Esra Karslioglu French is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (13 papers), Diabetes Management and Research (11 papers) and BRCA gene mutations in cancer (8 papers). Esra Karslioglu French collaborates with scholars based in United States, Hong Kong and Australia. Esra Karslioglu French's co-authors include Mary T. Korytkowski, Amy C. Donihi, Linwah Yip, Sally E. Carty, Donald K. Scott, Andrew F. Stewart, Yuri E. Nikiforov, Glory Koerbel, Marina N. Nikiforova and Raja R. Seethala and has published in prestigious journals such as Nature Communications, Diabetes Care and Cancer.

In The Last Decade

Esra Karslioglu French

24 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esra Karslioglu French United States 12 481 286 231 118 48 29 644
Angelo Lauria Italy 12 259 0.5× 193 0.7× 179 0.8× 65 0.6× 35 0.7× 19 416
Silvia Velázquez-García Spain 12 194 0.4× 180 0.6× 376 1.6× 250 2.1× 47 1.0× 15 665
Jun Murai Japan 16 458 1.0× 110 0.4× 107 0.5× 154 1.3× 82 1.7× 29 680
Stephen P. Lake United Kingdom 10 272 0.6× 327 1.1× 476 2.1× 113 1.0× 19 0.4× 17 815
Daniele Cappellani Italy 12 309 0.6× 76 0.3× 88 0.4× 91 0.8× 32 0.7× 30 495
Vanessa Preumont Belgium 13 340 0.7× 76 0.3× 173 0.7× 110 0.9× 45 0.9× 44 498
Garry S. Tobin United States 12 362 0.8× 136 0.5× 107 0.5× 172 1.5× 25 0.5× 19 521
Hüsniye Başer Türkiye 12 329 0.7× 47 0.2× 199 0.9× 33 0.3× 57 1.2× 48 412
Jeng‐Yueh Hsiao Taiwan 14 193 0.4× 66 0.2× 83 0.4× 85 0.7× 74 1.5× 18 372
Wenli Cheng China 10 152 0.3× 54 0.2× 62 0.3× 72 0.6× 40 0.8× 32 352

Countries citing papers authored by Esra Karslioglu French

Since Specialization
Citations

This map shows the geographic impact of Esra Karslioglu French's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esra Karslioglu French with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esra Karslioglu French more than expected).

Fields of papers citing papers by Esra Karslioglu French

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esra Karslioglu French. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esra Karslioglu French. The network helps show where Esra Karslioglu French may publish in the future.

Co-authorship network of co-authors of Esra Karslioglu French

This figure shows the co-authorship network connecting the top 25 collaborators of Esra Karslioglu French. A scholar is included among the top collaborators of Esra Karslioglu French based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esra Karslioglu French. Esra Karslioglu French is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martens, Thomas W., Holly Willis, Richard M. Bergenstal, et al.. (2025). A Randomized Controlled Trial Using Continuous Glucose Monitoring to Guide Food Choices and Diabetes Self-Care in People with Type 2 Diabetes not Taking Insulin. Diabetes Technology & Therapeutics. 27(4). 261–270. 2 indexed citations
2.
3.
Tjendra, Youley, Jaylou M. Velez Torres, Carmen Gomez‐Fernandez, et al.. (2024). Parsing the thyroid cytopathology suspicious for malignancy diagnosis through molecular‐derived risk of malignancy and other related parameters: Insights into nodule characteristics and practice patterns. Cancer Cytopathology. 133(1). e22904–e22904. 1 indexed citations
4.
Nikitski, Alyaksandr V., Cihan Kaya, Esra Karslioglu French, et al.. (2024). Reappraisal of BRAFK601E-positive thyroid tumors in the NIFTP era. Endocrine Related Cancer. 31(12).
5.
Martens, Thomas W., Holly Willis, Davida Kruger, Esra Karslioglu French, & Devin Steenkamp. (2024). 356-OR: A Randomized Controlled Trial Using Continuous Glucose Monitoring (CGM) to Guide Food Choices and Diabetes Self-Care in People with Type 2 Diabetes Not Taking Insulin. Diabetes. 73(Supplement_1). 1 indexed citations
6.
Weiner, Mark G., Alice Livshits, Jeremiah R. Brown, et al.. (2024). Domain generalization for enhanced predictions of hospital readmission on unseen domains among patients with diabetes. Artificial Intelligence in Medicine. 158. 103010–103010.
7.
French, Esra Karslioglu, et al.. (2023). A Payer–Provider Partnership for Endocrine Targeted Automatic eConsults: Implementation and Early Impact on Diabetes and Cost Outcomes. Population Health Management. 26(3). 168–176. 1 indexed citations
8.
Ohori, N. Paul, Sheldon Bastacky, Linwah Yip, et al.. (2023). Molecular‐derived risk of malignancy and the related positive call rate of indeterminate thyroid cytology diagnoses as quality metrics for individual cytopathologists. Cancer Cytopathology. 132(2). 109–118. 3 indexed citations
9.
10.
Liu, Jason B., Abigail I. Wald, Alyaksandr V. Nikitski, et al.. (2022). Performance of a Multigene Genomic Classifier in Thyroid Nodules with Suspicious for Malignancy Cytology. Thyroid. 32(12). 1500–1508. 25 indexed citations
11.
French, Esra Karslioglu, Linwah Yip, Marina N. Nikiforova, et al.. (2022). A thyroid EIF1AX story: how clinical, cytologic, and molecular surveillance led to appropriate management. Journal of the American Society of Cytopathology. 12(2). 105–111. 2 indexed citations
12.
Yip, Linwah, Raja R. Seethala, Simion I. Chiosea, et al.. (2022). Clinicopathologic Characteristics and Postsurgical Follow-Up of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in the Postnomenclature Revision Era. Thyroid. 32(11). 1346–1352. 13 indexed citations
13.
14.
Carty, Sally E., N. Paul Ohori, Kelly L. McCoy, et al.. (2020). The Clinical Utility of Molecular Testing in the Management of Thyroid Follicular Neoplasms (Bethesda IV Nodules). Annals of Surgery. 272(4). 621–627. 36 indexed citations
15.
16.
French, Esra Karslioglu, Amy C. Donihi, & Mary T. Korytkowski. (2019). Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. BMJ. 365. l1114–l1114. 117 indexed citations
17.
Puri, Sapna, Nilotpal Roy, Holger A. Russ, et al.. (2018). Replication confers β cell immaturity. Nature Communications. 9(1). 485–485. 109 indexed citations
18.
Donihi, Amy C., et al.. (2018). Readmission and Comprehension of Diabetes Education at Discharge (ReCoDED Study). Diabetes. 67(Supplement_1). 1 indexed citations
19.
French, Esra Karslioglu, et al.. (2011). cMyc Is a Principal Upstream Driver of β-Cell Proliferation in Rat Insulinoma Cell Lines and Is an Effective Mediator of Human β-Cell Replication. Molecular Endocrinology. 25(10). 1760–1772. 46 indexed citations
20.
Donihi, Amy C., et al.. (2008). Effect of a diabetes order set on glycaemic management and control in the hospital. BMJ Quality & Safety. 17(6). 464–468. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelo Lauria Breakdown of academic impact, for papers by Silvia Velázquez-García Breakdown of academic impact, for papers by Jun Murai Breakdown of academic impact, for papers by Stephen P. Lake Breakdown of academic impact, for papers by Daniele Cappellani Breakdown of academic impact, for papers by Vanessa Preumont Breakdown of academic impact, for papers by Garry S. Tobin Breakdown of academic impact, for papers by Hüsniye Başer Breakdown of academic impact, for papers by Jeng‐Yueh Hsiao Breakdown of academic impact, for papers by Wenli Cheng
Rankless by CCL
2026